Picture [iito] Männer Ballett 650x80px
Organisation › Details

SV Life Sciences Advisers LLP

SV Life Sciences is a leading, international life sciences venture capital firm. SVLS affiliated funds have been investing in life sciences companies since the early 1980s and the Firm closed its first dedicated life sciences fund in 1994. SVLS’ team of 32 professionals is organized according to experience and specialization into three practice areas: Biotechnology/Biopharmaceuticals, Medical Devices/Instrumentation, and Healthcare Services/Healthcare IT. These individuals’ diverse and complementary skill sets and experiences enable SVLS to tailor an investment team for almost any life science business. Typically, SVLS recruits operating executives, called Venture Partners, who have distinguished careers in the life sciences fields and can bring extensive operating expertise to the SVLS portfolio of investments. They assist in sourcing, building and exiting investments successfully. In some cases, these individuals are promoted to serve as Partners and/or Managing Partners within the Firm. SVLS employs a close symbiosis between operating and financial professionals which has led to significant success over five investment funds. SVLS has offices in Boston, London and San Francisco. *


Period Start 2005-08-02 existent
Period End 2017-04-10 renamed
  Group SV Health Investors (Group)
  Today SV Health Investors LLP
  Successor SV Health Investors LLP
Product Industry fund, biotech / life sciences
Region Region London, Greater London
  Country United Kingdom (GB)
  Street 71 Kingsway
  City WX2B London
  Tel +44-20-7421-7070
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Kesios Therapeutics Ltd.. (12/2/15). "Press Release: Kesios Therapeutics Raises £19 Million in Series A Financing. Builds Management Team Led by Dr. Paolo Paoletti as CEO". London.
Record changed: 2018-10-30


Picture ConsulTech GmbH RnD Credit Germany 650x80px

More documents for SV Health Investors (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group Digital Medicine & Medtech Showcase 2021 at BTS2021 651x81

» top